text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 56776-01-3 | Product Number: T2954

Tulobuterol Hydrochloride


Purity: >98.0%(T)(HPLC)
Synonyms:
  • 2-tert-Butylamino-1-(2-chlorophenyl)ethanol Hydrochloride
Product Documents:
100MG
€32.00
1   ≥40 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number T2954
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__2H__1__8ClNO·HCl = 264.19 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Hygroscopic
CAS RN 56776-01-3
Related CAS RN 41570-61-0
Reaxys Registry Number 5646719
PubChem Substance ID 253662260
Merck Index (14) 9811
MDL Number

MFCD00214398

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 159.0 to 164.0 °C
Properties (reference)
Melting Point 160 °C
Solubility (soluble in) Acetone
Solubility (insoluble in) Ether
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H302 : Harmful if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Related Laws:
RTECS# DN8785000
Transport Information:
HS Number 2922190090
Application
Tulobuterol: A β2-Adrenergic Receptor Agonist

Tulobuterol is a β2-adrenergic receptor agonist to induce relaxation of airway smooth muscle cells. The mechanism of action is explained as follows. Occupation of β2-adrenergic receptors by tulobuterol results in the activation of the adenylyl cyclase (AC), leading to an increase in intracellular cyclic AMP [A2381] and activation of protein kinase A (PKA). PKA phosphorylates Ca2+-ATPase, resulting in opening of Ca2+-activated K+ channels, decreasing intracellular Ca2+ concentration, and also decreased myosin light chain kinase (MLCK) activity. Tulobuterol transdermal patch as a controlled-release drug delivery system is used for medical purposes. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.